Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

4.24
Delayed Data
As of 3:44pm ET
 -0.19 / -4.29%
Today’s Change
3.49
Today|||52-Week Range
10.98
-1.62%
Year-to-Date

Today’s Trading

Previous close4.43
Today’s open4.38
Day’s range4.20 - 4.51
Volume148,492
Average volume (3 months)248,265
Market cap$218.1M
Dividend yield--
Data as of 3:44pm ET, 05/24/2017

Growth & Valuation

Earnings growth (last year)-820.59%
Earnings growth (this year)+61.90%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.34

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...+0.04+0.69%
CDXSCodexis Inc-0.20-4.40%
ARWRArrowhead Pharmaceut...-0.04-2.44%
BSTCBiospecifics Technol...-0.68-1.34%
Data as of 3:59pm ET, 05/24/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$0.00
Annual profit (last year)-$57.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts